Serum sickness-like reactions after placement of sirolimus-eluting stents [2]

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 2, 2007, Pages 201-202

  Rana, Jamal S ^a   Sheikh, Javed ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METHACRYLIC ACID; POLYETHYLENE; POLYMER; PREDNISONE; RAPAMYCIN; TICLOPIDINE; VINYL ACETATE;

ADULT; AGED; ARTHRALGIA; ARTHRITIS; CASE REPORT; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG ELUTING STENT; DRUG SUBSTITUTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LETTER; LEUKOCYTE; MALE; MYALGIA; NEUTROPHIL; PRIORITY JOURNAL; RASH; SERUM SICKNESS; URTICARIA;

EID: 33846815269     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60699-0     Document Type: Letter

References (5)

1. Mueller T. Stories of Survival and Hope Mark the One Million Patient Milestone for the CYPHER Sirolimus-Eluting Coronary Stent. Miami Lakes, FL: COMTEX; 2005.
2. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47:175-181.
3. Instructions for Use: Cypher Sirolimus-Eluting Coronary Stent. Miami Lakes, FL: Cordis Corp; 2006.
4. Azarbal B, Currier JW. Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer? J Am Coll Cardiol. 2006;47:182-183.
5. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-2809.